JNJ - JOHNSON & JOHNSON
Close
145.945
-0.660 -0.452%
Share volume: 210,821
Last Updated: Tue 07 Jan 2025 08:30:05 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$146.60
-0.66
-0.45%
View ratios
| Fiscal Date | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2023-04-28 | 2023-07-31 | 2023-10-27 | 2024-02-16 | 2024-05-01 | 2024-07-25 | |
| Cash flow financing | 6.138 B | -5.991 B | -11.317 B | -4.655 B | 546.000 M | 7.544 B | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 3.257 B | 4.182 B | 7.489 B | 7.863 B | 3.657 B | 5.633 B | |
| Net income | -68.000 M | 5.144 B | 26.028 B | 4.049 B | 3.255 B | 4.686 B | |
| Depreciation | 1.880 B | 1.934 B | 1.829 B | 1.843 B | 1.815 B | 1.782 B | |
| Changes in inventories | 12.809 B | 12.888 B | 11.198 B | 11.181 B | 11.383 B | 12.169 B | |
| Changes in receivables | 16.350 B | 16.777 B | 14.798 B | 14.873 B | 14.946 B | 15.794 B | |
| Investing Cashflow | 3.315 B | -3.776 B | 2.541 B | -1.202 B | -464.000 M | -13.687 B | |
| Net Borrowings | 25.373 B | 14.700 B | 2.214 B | 1.891 B | 2.959 B | 11.637 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -863.000 M | -1.124 B | -967.000 M | -1.589 B | -807.000 M | -976.000 M | |
| Cash Change | 24.613 B | 28.505 B | 23.511 B | 22.927 B | 26.218 B | 25.475 B |